MOSCHETTA, DONATO
MOSCHETTA, DONATO
Dipartimento di Scienze Farmaceutiche
Non-stenotic fibro-calcific aortic valve as a predictor of myocardial infarction recurrence
2024 V. A Myasoedova, M. Chiesa, N. Cosentino, A. Bonomi, M. Ludergnani, M. Bozzi, V. Valerio, D. Moschetta, I. Massaiu, V. Mantegazza, G. Marenzi, P. Poggio
Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists
2024 V.A. Myasoedova, M. Bozzi, V. Valerio, D. Moschetta, I. Massaiu, V. Rusconi, D. Di Napoli, M. Ciccarelli, V. Parisi, P. Agostoni, S. Genovese, P. Poggio
Whole-Blood Transcriptome Unveils Altered Immune Response in Acute Myocardial Infarction Patients With Aortic Valve Sclerosis
2024 L. Piacentini, V.A. Myasoedova, M. Chiesa, C. Vavassori, D. Moschetta, V. Valerio, G. Giovanetti, I. Massaiu, N. Cosentino, G. Marenzi, P. Poggio, G.I. Colombo
Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
2023 V.A. Myasoedova, V. Parisi, D. Moschetta, V. Valerio, M. Conte, I. Massaiu, M. Bozzi, F. Celeste, D. Leosco, G. Iaccarino, S. Genovese, P. Poggio
Dysregulation of Iron Metabolism-Linked Genes at Myocardial Tissue and Cell Levels in Dilated Cardiomyopathy
2023 I. Massaiu, J.S. Campodonico, M. Mapelli, E. Salvioni, V. Valerio, D. Moschetta, V.A. Myasoedova, M.D. Cappellini, G. Pompilio, P. Poggio, P. Agostoni
UNRAVELLING SEX-DEPENDENT MECHANISMS IN CALCIFIC AORTIC VALVE STENOSIS
2022 D. Moschetta
Extraction-Free Absolute Quantification of Circulating miRNAs by Chip-Based Digital PCR
2022 Y. D’Alessandra, V. Valerio, D. Moschetta, I. Massaiu, M. Bozzi, M. Conte, V. Parisi, M. Ciccarelli, D. Leosco, V.A. Myasoedova, P. Poggio
Red Flags, Prognostic Impact, and Management of Patients With Cardiac Amyloidosis and Aortic Valve Stenosis: A Systematic Review and Meta-Analysis
2022 V.A. Myasoedova, M. Conte, V. Valerio, D. Moschetta, I. Massaiu, L. Petraglia, D. Leosco, P. Poggio, V. Parisi
Purinergic Receptor P2Y2 Stimulation Averts Aortic Valve Interstitial Cell Calcification and Myofibroblastic Activation
2022 D. Moschetta, E. Di Maria, V. Valerio, I. Massaiu, M. Bozzi, P. Songia, Y. D'Alessandra, V.A. Myasoedova, P. Poggio
Epicardial Adipose Tissue-Derived IL-1β Triggers Postoperative Atrial Fibrillation
2022 S. Cabaro, M. Conte, D. Moschetta, L. Petraglia, V. Valerio, S. Romano, M.F. Di Tolla, P. Campana, G. Comentale, E. Pilato, V. D’Esposito, A. Di Mauro, M. Cantile, P. Poggio, V. Parisi, D. Leosco, P. Formisano
From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
2022 A.V. Poznyak, L. Litvinova, P. Poggio, D. Moschetta, V.N. Sukhorukov, A.N. Orekhov
Sex-Specific Cell Types and Molecular Pathways Indicate Fibro-Calcific Aortic Valve Stenosis
2022 V.A. Myasoedova, I. Massaiu, D. Moschetta, M. Chiesa, P. Songia, V. Valerio, V. Alfieri, R. Capoulade, D. Trabattoni, D. Andreini, E. Mass, V. Parisi, P. Poggio
Pharmacological agents affecting mitophagy and inflammation
2022 E. Borisov, E. Bezsonov, D. Lyukmanov, P. Poggio, D. Moschetta, V. Valerio
Enduring Reactive Oxygen Species Emission Causes Aberrant Protein S-Glutathionylation Transitioning Human Aortic Valve Cells from a Sclerotic to a Stenotic Phenotype
2022 V. Valerio, G. Keceli, D. Moschetta, B. Porro, M. Ciccarelli, I. Massaiu, P. Songia, A.S. Maione, V. Alfieri, V.A. Myasoedova, M. Zanobini, N. Paolocci, P. Poggio
Aortic Valve Sclerosis as an Important Predictor of Long-Term Mortality in Patients With Carotid Atheromatous Plaque Requiring Carotid Endarterectomy
2021 V.A. Myasoedova, C. Saccu, M. Chiesa, P. Songia, V. Alfieri, I. Massaiu, V. Valerio, D. Moschetta, P. Gripari, M. Naliato, L. Cavallotti, R. Spirito, P. Trabattoni, P. Poggio
Putative circulating micrornas are able to identify patients with mitral valve prolapse and severe regurgitation
2021 P. Songia, M. Chiesa, V. Alfieri, I. Massaiu, D. Moschetta, V. Myasoedova, V. Valerio, L. Fusini, P. Gripari, M. Zanobini, P. Poggio
The role of glycemic variability in cardiovascular disorders
2021 V. Alfieri, V.A. Myasoedova, M.C. Vinci, M. Rondinelli, P. Songia, I. Massaiu, N. Cosentino, D. Moschetta, V. Valerio, M. Ciccarelli, G. Marenzi, S. Genovese, P. Poggio
Evaluation of oxford nanopore minion rna-seq performance for human primary cells
2021 I. Massaiu, P. Songia, M. Chiesa, V. Valerio, D. Moschetta, V. Alfieri, V.A. Myasoedova, M. Schmid, L. Cassetta, G.I. Colombo, Y. D'Alessandra, P. Poggio
Relationship Between Plasma Osteopontin and Arginine Pathway Metabolites in Patients With Overt Coronary Artery Disease
2020 D. Moschetta, M.N.D. Di Minno, B. Porro, G.L. Perrucci, V. Valerio, V. Alfieri, I. Massaiu, A.N. Orekhov, A. Di Minno, P. Songia, V. Cavalca, V.A. Myasoedova, P. Poggio
Cyclophilin A inhibition as potential treatment of human aortic valve calcification
2020 G.L. Perrucci, P. Songia, D. Moschetta, V.A. Barbagallo, V. Valerio, V.A. Myasoedova, V. Alfieri, I. Massaiu, M. Roberto, M. Malesevic, G. Pompilio, P. Poggio